To read this content please select one of the options below:

Supply chain risk factor assessment of Indian pharmaceutical industry for performance improvement

Astha Sharma (IIT Roorkee, Roorkee, India)
Dinesh Kumar (IIT Roorkee, Roorkee, India)
Navneet Arora (IIT Roorkee, Roorkee, India)

International Journal of Productivity and Performance Management

ISSN: 1741-0401

Article publication date: 28 October 2022

Issue publication date: 3 January 2024

583

Abstract

Purpose

The purpose of the present work is to improve the industry performance by identifying and quantifying the risks faced by the Indian pharmaceutical industry (IPI). The risk values for the prominent risks and overall industry are determined based on the four risk parameters, which would help determine the most contributive risks for mitigation.

Design/methodology/approach

An extensive literature survey was done to identify the risks, which were also validated by industry experts. The finalized risks were then evaluated using the fuzzy synthetic evaluation (FSE) method, which is the most suitable approach for the risk assessment with parameters having a set of different risk levels.

Findings

The three most contributive sub-risks are counterfeit drugs, demand fluctuations and loss of customers due to partners' poor service performance, while the main risks obtained are demand, financial and logistics. Also, the overall risk value indicates that the industry faces medium to high risk.

Practical implications

The study identifies the critical risks which need to be mitigated for an efficient industry. The industry is most vulnerable to the demand risk category. Therefore, the managers should minimize this risk by mitigating its sub-risks, like demand fluctuations, bullwhip effect, etc. Another critical sub-risk, the counterfeit risk, should be managed by adopting advanced technologies like blockchain, artificial intelligence, etc.

Originality/value

There is insufficient literature focusing on risk quantification. Therefore, this work addresses this gap and obtains the industry's most critical risks. It also discusses suitable mitigation strategies for better industry performance.

Keywords

Citation

Sharma, A., Kumar, D. and Arora, N. (2024), "Supply chain risk factor assessment of Indian pharmaceutical industry for performance improvement", International Journal of Productivity and Performance Management, Vol. 73 No. 1, pp. 119-157. https://doi.org/10.1108/IJPPM-01-2022-0035

Publisher

:

Emerald Publishing Limited

Copyright © 2022, Emerald Publishing Limited

Related articles